Hartford Financial Management’s Emmaus Life Sciences, Inc. Common Stock EMMA Stock Holding History

Hartford Financial Management’s Portfolio EMMA Stock Details EMMA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q3	–	Sell	-483	Closed	-$5K	–	429
2018 Q2	$5K	Hold	483	–	–	﹤0.01%	360
2018 Q1	$3K	Sell	483 -250	-34%	-$4.05K	﹤0.01%	313
2017 Q4	$14K	Hold	733	–	–	0.01%	248
2017 Q3	$16K	Buy	+733	New	+$17.1K	0.01%	259

Other funds holding EMMA

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

Cannell & Co New York $3.15B AUM 30.62% 1-Year Est. Return

FFA

First Foundation Advisors Irvine, California $2.48B AUM 18.56% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Hartford Financial Management's EMMA Position: Q3 2018 in Review

Hartford Financial Management sold out of Emmaus Life Sciences, Inc. Common Stock (EMMA) in Q3 2018, closing a stake of 483 shares — an estimated $5K sold.

Hartford Financial Management first reported a position in EMMA in Q3 2017 and held it in 4 quarters. The position peaked at $16K in Q3 2017. 9 funds tracked by Wall St. Rank hold EMMA as of Q3 2018.

Hartford Financial Management reported no remaining Emmaus Life Sciences, Inc. Common Stock position as of Q3 2018 after selling out during the quarter.
Hartford Financial Management sold 483 Emmaus Life Sciences, Inc. Common Stock shares in Q3 2018, an estimated $5K.
Hartford Financial Management first reported a position in Emmaus Life Sciences, Inc. Common Stock in Q3 2017 and held it in 4 quarters.
Hartford Financial Management's Emmaus Life Sciences, Inc. Common Stock position peaked at $16K in Q3 2017.
9 funds tracked by Wall St. Rank held Emmaus Life Sciences, Inc. Common Stock as of Q3 2018.

Based on Hartford Financial Management's 13F filing for Q3 2018, filed 1 Nov 2018.